Antifungal medication :: Consumers survey results of 2019

Results

Consumers survey results of 2019 in category

Dermatology, means for external use / Antifungal medication

The annual ratings by results of Consumers survey calculated as average arithmetic mean rank, obtained in each of 4 quarters of year.

	I quarter (january—march)
	II quarter (april—june)
	III quarter (july—september)
	IV quarter (october—december)

1.	3	Lamikon (Farmak)	23.53%	5

2.	12	Клотримазол (ORGANOSYN)	21.57%	4.59

3.	1	Екзодерил (Sandoz)	21.57%	4.57

4.	5	Кандібене (ratiopharm)	13.07%	3.07

5.	7	Клотримазол (Борщагівський ХФЗ)	13.73%	2.92

6.		Амодерм Нео (Actavis)	3.92%	2.43

7.	2	Lamisil (Novartis OTC)	10.46%	2.26

8.	4	Canespor (Bayer)	8.50%	2.05

9.	6	Exo-derm (Pharmaceutical company “Zdorovya”)	8.50%	2.04

10.	13	Флуконазол-Дарниця (Darnitsa)	9.15%	1.96

11.	15	Канестен (Bayer)	7.84%	1.58

12.		Естезифін (Farmak)	5.23%	1.30

13.	9	Zalain (Egis Pharmaceuticals)	5.88%	1.28

14.	27	Флуконазол (Pharmaceutical company “Zdorovya”)	5.23%	1.24

15.	14	Тримістин-Дарниця (Darnitsa)	5.88%	1.12

16.		Міконазол (Elegant India)	5.23%	1.09

17.	11	Клотримазол-Фітофарм (Фітофарм)	3.92%	1.03

18.		Цикложен (Pro-Pharma)	3.27%	1

19.	31	Флуконазол (Red star)	4.58%	0.97

20.	23	Мікогель-КМП (Arterium Corporation)	4.58%	0.94

21.	10	Кетоконазол (Фітофарм)	3.92%	0.93

22.		Екзік (Vishpha \| Фармацевтична фабрика Vishpha)	0.65%	0.88

23.	19	Флюконазол (Norton)	3.92%	0.86

24.	32	Мікогал (Teva)	3.27%	0.82

25.	26	Антифунгін (Монфарм)	3.27%	0.79

26.	8	Мікоцид (Ilan Pharm)	3.27%	0.73

27.	35	Травоген (Bayer)	2.61%	0.69

28.	21	Нітрофунгін (Teva)	3.27%	0.65

29.	18	Пимафуцин крем (Delta Medical)	3.27%	0.60

30.	35	Мікомакс (Zentiva)	3.27%	0.58

31.	17	Теймурова паста (Ternopharm)	3.27%	0.56

32.	25	Viosept (Jelfa)	2.61%	0.55

32.	33	Флуконазол (Астрафарм)	2.61%	0.55

32.	24	Флуконазол (Genom Biotech)	2.61%	0.55

35.	22	Еконазол (Red star)	2.61%	0.54

36.	38	Мікосист (Gedeon Richter)	2.61%	0.53

37.		Фуніт (Нобель Ілач)	1.96%	0.48

38.	34	Флуконазол (Vitaminy)	1.96%	0.47

38.	28	Цинкундан (Arterium Corporation)	1.96%	0.47

40.	20	Тербінокс (Johnson & Johnson)	1.96%	0.38

41.	29	Микостоп (Genom Biotech)	1.31%	0.29

42.	37	Мікофін (Нобель Ілач)	1.31%	0.18

43.	~	Міконазол Гексал (Sandoz)	0.65%	0.17

44.	36	Онабет (Glenmark Farmaceuticals Limited)	0.65%	0.15

–.		Екодакс (Johnson & Johnson)	0.00%	0

–.		Клотрисал-КМП (Arterium Corporation)	0.00%	0

–.		Міконазол-Дарниця (Darnitsa)	0.00%	0

–.	30	Мікосептин (Zentiva)	0.00%	0

–.		Міфунгар (Zentiva)	0.00%	0

–.		Фунготербін (Nizhpharm)	0.00%	0

View results of current, 2024 year

Show all preparations

Print version

Normed consumer's score are calculated by 5-score scale, accordingly to the methodic of the research.

The participant which took the 1st place in this rating is by opinion of Ukrainian consumers is the best choice in 2019, recommendation of consumers #1 in the category “Antifungal medication”.

Using this rating is only possible with obligatory link to the source.

This rating was built as a result of the study of social preferences in 2019, under the “Favorites of Success” Contest in Ukraine and it’s the free information. In case of full or partial republishing of the information drawn from this rating, it is obligatory to mention the name of the “Favorites of Success” Contest in printed publications, or put an active hyperlink to this page in the electronic media. Details…

Comments(8)

all in a row | positive | negative

Your Name:		(not necessarily)	or
Your E-mail:		(to receive responses)	or

You may sign in using:

Your Comment

Medicine	Aye	Nay

Enter digits displayed on picture *:

Please be polite! Although that modertors of this web-portal are excessively democratic, any unethical, unqotable or just rude expressions, which abuse other visitors of this web site, can be deleted. Also will be deleted any spam and public comments with private phone numbers.